Ed Sheeran Apologizes Amid Controversy Over Gaza and Rapper's Exclusion
Ed Sheeran opened his concert in Philadelphia not with a song, but with an apology, stating he had a difficult week, made tough decisions, and committed errors he regrets. Appearing emotional, Sheeran addressed the audience at his first show since the controversy erupted over the exclusion of American rapper Macklemore from the remainder of his US tour.
The dispute began when Macklemore expressed support for Palestinians during tour dates earlier in September, after which he was removed from subsequent shows. Macklemore accused stadium authorities of pressuring for his removal, while Sheeran previously stated the decision was not directly his, and that he attempted to find a resolution with the relevant parties.
Speaking on stage, Sheeran affirmed artists' right to express their views, admitting he did not anticipate being at the center of a broad debate on free expression and artists' roles in public affairs. He also addressed the war in Gaza, describing the events there as "catastrophic and unjustified," and stated that civilians bear the brunt of conflicts. He also referenced what he called the injustice faced by Palestinians in the West Bank.
The controversy widened in recent days with several artists withdrawing from opening slots in solidarity with Macklemore, including Lukas Graham, Aaron Raao, and the band Beoga. Macklemore later announced a $1 million donation to organizations supporting Palestinians.
Sheeran's remarks come as Macklemore's situation has evolved from a dispute over tour participation to a broader discussion within the music industry, marked by artist withdrawals, donations related to the Gaza humanitarian crisis, and ongoing reactions from artists and celebrities in the US and abroad.
The same event, reported separately by each outlet. Open a few to compare what different newsrooms emphasize — and what they leave out.
Not the same event — other stories that share this one’s people, places, or theme: background, reactions, and follow-ups.
